Alterity Therapeutics Ltd

ATHE chart

Alterity Therapeutics Ltd news

• Alterity Therapeutics (ASX:ATH) Shares Fall: What’s Behind the Drop?

  Kalkine · Oct 27, 1:27 AM EDT

• Alterity Therapeutics Ltd. Estimates – ASX:ATH

  TradingView · Oct 24, 2:08 PM EDT

• Alterity Therapeutics Ltd (NASDAQ: ATHE) Share Price, ATHE Stock News, ATHE Share Price & Updates

  Kalkine · Oct 23, 4:00 PM EDT

• ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer)

  Stock Titan · Oct 23, 6:04 AM EDT

• Alterity Therapeutics (ASX:ATH): FY26 Financial Results and ATH434 Phase 3 Plans

  Kalkine · Oct 23, 1:27 AM EDT

• Alterity Therapeutics to Issue 2,000,000 Options as Payment for Services, Subject to Shareholder Approval by 20 November 2026

  Kalkine · Oct 23, 1:22 AM EDT

• Alterity Therapeutics Issues 1,290,000 Unlisted Options Expiring 8 October 2031 at USD 0.2767

  Kalkine · Oct 22, 7:55 PM EDT

• Alterity Therapeutics Issues 912,000 Unlisted Options Expiring 8 October 2031

  Kalkine · Oct 22, 7:55 PM EDT

• CEO incentive of up to 100% of base salary approved at Alterity Therapeutics (ATHE).

  Stock Titan · Oct 21, 6:04 AM EDT

• Alterity Therapeutics to Hold 2026 Annual General Meeting on 20 November with Seven Board and Equity Resolutions

  Kalkine · Oct 21, 1:08 AM EDT

• Alterity Therapeutics Revises CEO Dr David Stamler's Remuneration Package Effective 15 October 2026

  Kalkine · Oct 21, 1:02 AM EDT

• Ather Energy (NSEI:ATHERENERG) Stock Sees Modest Fair Value Lift On Stronger Growth Assumptions

  Yahoo Finance · Oct 9, 1:19 PM EDT

Alterity Therapeutics Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-21
• 6-KFORM 6-K2026-10-21
• 6-KFORM 6-K2026-10-19
• 6-KFORM 6-K2026-10-09
• 6-KFORM 6-K2026-10-05
• 6-KFORM 6-K2026-09-25
• 6-KFORM 6-K2026-09-23
• 6-KFORM 6-K2026-09-18
• 6-KFORM 6-K2026-09-16

About Alterity Therapeutics Ltd

Ticker

ATHE (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Melbourne

Incorporated in

Australia

Fiscal year end

June 30

SEC CIK

1131343

Former names

PRANA BIOTECHNOLOGY LTD

Frequently asked questions